Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK2584786A in Children 6-35 Months
NCT01195779Phase 2Terminated
- Sponsor
- GSK
- Start
- Sep 2010
- Primary completion
- Mar 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Influenza vaccine (adjuvanted quadrivalent, GSK2584786A) in influenza, sponsored by GSK. Started Sep 2010; status: terminated.
02
Drugs
Influenza vaccine (adjuvanted quadrivalent, GSK2584786A)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01195779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01195779.